Search | LIFE-ND Graduate Community

Anjali Shinde added blog Health
2026-05-07 10:00:05 -

Bevacizumab Biosimilar Market Competitive Landscape and Innovation Trends
The Bevacizumab Biosimilar Market Share landscape is becoming increasingly competitive as major pharmaceutical companies expand biosimilar commercialization strategies and strengthen global oncology distribution networks. Companies including Pfizer, Biocon, Samsung Bioepis, Celltrion, Dr. Reddy’s Laboratories, and Amgen currently hold significant market positions due to strong...

0 Comments 0 Shares 160 Views 0 Reviews

Please log in to like, share and comment!
Rushikesh Nemishte added blog Health
2026-06-22 10:07:16 -

Bevacizumab Biosimilar Market Overview
The Bevacizumab Biosimilar Market was valued at $2.18 billion in 2024 and is projected to reach $5 billion by 2035, growing at a CAGR of 7.8%. Bevacizumab biosimilars offer cost-effective alternatives to the reference biologic Avastin, treating multiple cancers by inhibiting vascular endothelial growth factor (VEGF). The market encompasses various formulation types including intravenous and...

0 Comments 0 Shares 84 Views 0 Reviews

Please log in to like, share and comment!
Anjali Shinde added blog Health
2026-07-17 05:55:19 -

Investment Opportunities in the Bevacizumab Biosimilar Market
The Bevacizumab Biosimilar Market growth continues to accelerate as oncology and ophthalmology sectors increasingly embrace cost-effective alternatives to the reference biologic for anti-angiogenic therapy. With bevacizumab being a cornerstone treatment for multiple solid tumors including colorectal, lung, breast, and glioblastoma, alongside expanding off-label use in age-related macular...

0 Comments 0 Shares 99 Views 0 Reviews

Please log in to like, share and comment!